ARCHIVES

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 42 | November 11, 2011

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986